Evisort
United States
- San Mateo, California
- 11/05/2022
- Series C
- $100,000,000
Founded in 2016 by Harvard Law and MIT alumni, Evisort is the leading provider of contract management and AI technology for legal, procurement, sales, finance, and IT teams. Evisort’s Contract Intelligence Platform offers implementation within 30 days and fast ROI by centralizing contracts without file migration, using AI to search and automatically track metadata and provisions without manual data entry, and enabling teams to efficiently draft, redline, approve, sign, report on, and renew contracts, all in one place. Evisort is headquartered in Silicon Valley and backed by leading strategic and institutional investors including General Atlantic, Vertex Ventures, M12 (Microsoft’s venture fund), Amity Ventures, Village Global, and Serra Ventures.
- Industry Software Development
- Website https://www.evisort.com/
- LinkedIn https://www.linkedin.com/company/evisort/
Vector 👻 | $10,000,000 | (May 14, 2026)
Avant Genomics | $3,000,000 | (May 14, 2026)
Data Mission | $1,000,000 | (May 14, 2026)
Origin Lab | $8,000,000 | (May 14, 2026)
CREATE Medicines | $122,000,000 | (May 14, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Dolfin | $2,460,580 | (May 14, 2026)
Saile Medical (Saile App) | $2,200,000 | (May 14, 2026)
4AM | $4,000,000 | (May 13, 2026)
Adfin | $18,000,000 | (May 13, 2026)